Abramson Cancer Center at Penn Medicine: Prostatic Neoplasms trials

The registry lists 17 Prostatic Neoplasms studies with Abramson Cancer Center at Penn Medicine as lead sponsor. 2 are open to participants now and 3 have results posted.

Early Phase 1 2Phase 1 2Phase 2 2No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Prostate Tissue BioBankRecruitingNCT06659614
• Hypofractionated WPPT With HDR BoostRecruitingNCT06591819Phase 2
• A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate CancerCompletedNCT02135653Results posted
• Functional MRI Use in Prostate Radiation Treatment PlanningCompletedNCT01985932Not applicableResults posted
• Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone TherapyCompletedNCT00589420Phase 2Results posted
• The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer PatientsCompletedNCT06604247Not applicable
• RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)CompletedNCT05176756Not applicable
• Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate CancerActive, not recruitingNCT05096338
• Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation TherapyCompletedNCT03535987
• Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate CancerActive, not recruitingNCT03334500Early Phase 1
• C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate CancerCompletedNCT02715583Early Phase 1
• Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate CancerCompletedNCT02479945Not applicable
• Proton Therapy for High Risk Prostate CancerWithdrawnNCT01811810Not applicable
• Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following ProstatectomyCompletedNCT01548807Phase 1
• Proton Radiation Therapy in Treating Patients With Prostate CancerTerminatedNCT01045226Not applicable
• MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the ProstateCompletedNCT01028885Phase 1
• Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer TreatmentCompletedNCT01018901Not applicable